$1.51 Billion is the total value of Eventide Asset Management's 121 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 18.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $58,155,000 | -1.1% | 721,700 | +0.2% | 3.85% | +0.6% |
XPO | XPO LOGISTICS INC | $54,116,000 | +11.0% | 1,130,000 | 0.0% | 3.58% | +12.9% | |
BLUE | Sell | BLUEBIRD BIO INC | $51,786,000 | +42.8% | 569,700 | -3.1% | 3.43% | +45.3% |
LOW | LOWES COS INC | $46,449,000 | +15.6% | 565,000 | 0.0% | 3.08% | +17.6% | |
LRCX | Sell | LAM RESEARCH CORP | $42,038,000 | +20.7% | 327,500 | -0.6% | 2.78% | +22.8% |
KAR | KAR AUCTION SVCS INC | $39,303,000 | +2.5% | 900,000 | 0.0% | 2.60% | +4.2% | |
CELG | CELGENE CORP | $37,988,000 | +7.5% | 305,300 | 0.0% | 2.52% | +9.4% | |
ABBV | Sell | ABBVIE INC | $36,183,000 | -31.2% | 555,300 | -33.9% | 2.40% | -30.1% |
STLD | STEEL DYNAMICS INC | $33,022,000 | -2.3% | 950,000 | 0.0% | 2.19% | -0.6% | |
SGEN | Sell | SEATTLE GENETICS INC | $33,002,000 | +11.7% | 525,000 | -6.2% | 2.18% | +13.6% |
SPLK | SPLUNK INC | $31,145,000 | +21.8% | 500,000 | 0.0% | 2.06% | +23.9% | |
WBC | WABCO HLDGS INC | $30,013,000 | +10.6% | 255,600 | 0.0% | 1.99% | +12.6% | |
CCI | Buy | CROWN CASTLE INTL CORP NEW | $29,119,000 | +9.6% | 308,300 | +0.7% | 1.93% | +11.5% |
W | Buy | WAYFAIR INCcl a | $28,303,000 | +130.7% | 699,000 | +99.7% | 1.87% | +134.8% |
CYBR | CYBERARK SOFTWARE LTD | $27,979,000 | +11.8% | 550,000 | 0.0% | 1.85% | +13.8% | |
IPHI | Sell | INPHI CORP | $27,095,000 | -24.0% | 555,000 | -30.5% | 1.79% | -22.7% |
STKL | Buy | SUNOPTA INC | $27,015,000 | -0.0% | 3,887,000 | +1.4% | 1.79% | +1.7% |
SNA | SNAP ON INC | $26,987,000 | -1.5% | 160,000 | 0.0% | 1.79% | +0.2% | |
ASML | ASML HOLDING N V | $26,560,000 | +18.4% | 200,000 | 0.0% | 1.76% | +20.4% | |
LEA | Sell | LEAR CORP | $26,051,000 | -43.8% | 184,000 | -47.4% | 1.72% | -42.8% |
NEP | Sell | NEXTERA ENERGY PARTNERS LP | $25,990,000 | +29.0% | 784,500 | -0.6% | 1.72% | +31.3% |
MGA | Sell | MAGNA INTL INC | $25,909,000 | -19.4% | 600,300 | -18.9% | 1.72% | -17.9% |
IDTI | INTEGRATED DEVICE TECHNOLOGY | $24,775,000 | +0.5% | 1,046,700 | 0.0% | 1.64% | +2.2% | |
DOOR | Buy | MASONITE INTL CORP NEW | $24,568,000 | +23.9% | 310,000 | +2.9% | 1.63% | +26.0% |
LOXO | Sell | LOXO ONCOLOGY INC | $24,364,000 | +2.5% | 579,000 | -21.8% | 1.61% | +4.3% |
PFPT | Sell | PROOFPOINT INC | $23,795,000 | -12.5% | 320,000 | -16.9% | 1.58% | -11.0% |
CRUS | Sell | CIRRUS LOGIC INC | $22,455,000 | -20.6% | 370,000 | -26.0% | 1.49% | -19.1% |
ROL | ROLLINS INC | $21,907,000 | +9.9% | 590,000 | 0.0% | 1.45% | +11.8% | |
FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $21,726,000 | -46.5% | 601,000 | -25.8% | 1.44% | -45.6% |
COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $21,665,000 | -33.0% | 2,153,612 | +3.7% | 1.43% | -31.9% |
ARW | ARROW ELECTRS INC | $21,656,000 | +3.0% | 295,000 | 0.0% | 1.43% | +4.7% | |
AYI | Buy | ACUITY BRANDS INC | $20,604,000 | -10.8% | 101,000 | +1.0% | 1.36% | -9.2% |
CAFD | Sell | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $20,078,000 | -0.4% | 1,479,600 | -4.8% | 1.33% | +1.3% |
VCYT | Sell | VERACYTE INC | $19,586,000 | +12.4% | 2,133,500 | -5.3% | 1.30% | +14.4% |
AY | Buy | ATLANTICA YIELD PLC | $19,346,000 | +11.7% | 923,000 | +3.1% | 1.28% | +13.7% |
TWLO | New | TWILIO INCcl a | $19,199,000 | – | 665,000 | +100.0% | 1.27% | – |
PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $17,916,000 | +7.1% | 890,000 | +1.0% | 1.19% | +8.9% |
AGIO | AGIOS PHARMACEUTICALS INC | $17,567,000 | +40.0% | 300,800 | 0.0% | 1.16% | +42.4% | |
XLRN | Buy | ACCELERON PHARMA INC | $17,309,000 | +58.1% | 653,900 | +52.5% | 1.15% | +61.0% |
INST | INSTRUCTURE INC | $15,678,000 | +19.7% | 670,000 | 0.0% | 1.04% | +21.8% | |
WCN | WASTE CONNECTIONS INC | $15,439,000 | +12.3% | 175,000 | 0.0% | 1.02% | +14.2% | |
HASI | Buy | HANNON ARMSTRONG SUST INFR C | $14,221,000 | +8.7% | 704,000 | +2.2% | 0.94% | +10.6% |
VMC | New | VULCAN MATLS CO | $13,253,000 | – | 110,000 | +100.0% | 0.88% | – |
WSO | WATSCO INC | $12,886,000 | -3.3% | 90,000 | 0.0% | 0.85% | -1.6% | |
WVE | Buy | WAVE LIFE SCIENCES LTD | $11,921,000 | +18.8% | 433,500 | +13.0% | 0.79% | +20.8% |
SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $11,581,000 | +3.1% | 370,000 | -16.9% | 0.77% | +4.9% |
ACAD | ACADIA PHARMACEUTICALS INC | $11,507,000 | +19.2% | 334,700 | 0.0% | 0.76% | +21.3% | |
TSLA | TESLA INC | $11,132,000 | +30.2% | 40,000 | 0.0% | 0.74% | +32.6% | |
BPMC | BLUEPRINT MEDICINES CORP | $10,597,000 | +42.6% | 265,000 | 0.0% | 0.70% | +45.0% | |
AYR | AIRCASTLE LTD | $10,342,000 | +15.7% | 428,600 | 0.0% | 0.68% | +17.9% | |
KITE | KITE PHARMA INC | $10,047,000 | +75.0% | 128,000 | 0.0% | 0.66% | +78.3% | |
STML | Buy | STEMLINE THERAPEUTICS INC | $9,289,000 | +2.0% | 1,086,400 | +27.6% | 0.62% | +3.7% |
XNCR | XENCOR INC | $8,228,000 | -9.1% | 344,000 | 0.0% | 0.54% | -7.5% | |
ONCE | SPARK THERAPEUTICS INC | $8,001,000 | +6.9% | 150,000 | 0.0% | 0.53% | +8.8% | |
DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $7,854,000 | -10.4% | 223,000 | -10.7% | 0.52% | -8.8% |
GWPH | GW PHARMACEUTICALS PLCads | $7,680,000 | +8.2% | 63,500 | 0.0% | 0.51% | +10.0% | |
ESSA PHARMA INC | $7,411,000 | +40.8% | 2,719,410 | 0.0% | 0.49% | +43.1% | ||
PANW | Sell | PALO ALTO NETWORKS INC | $7,324,000 | -44.2% | 65,000 | -38.1% | 0.48% | -43.2% |
ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $6,891,000 | +48.7% | 246,100 | +7.5% | 0.46% | +51.0% |
AIMT | New | AIMMUNE THERAPEUTICS INC | $6,736,000 | – | 310,000 | +100.0% | 0.45% | – |
PRTA | PROTHENA CORP PLC | $6,695,000 | +13.4% | 120,000 | 0.0% | 0.44% | +15.4% | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $6,584,000 | +6.0% | 75,000 | 0.0% | 0.44% | +7.9% | |
CERN | CERNER CORP | $6,368,000 | +24.3% | 108,200 | 0.0% | 0.42% | +26.7% | |
AVXS | New | AVEXIS INC | $6,158,000 | – | 81,000 | +100.0% | 0.41% | – |
GBT | GLOBAL BLOOD THERAPEUTICS IN | $6,080,000 | +155.0% | 165,000 | 0.0% | 0.40% | +160.0% | |
EXR | EXTRA SPACE STORAGE INC | $6,063,000 | -3.7% | 81,500 | 0.0% | 0.40% | -2.2% | |
RARE | ULTRAGENYX PHARMACEUTICAL IN | $5,924,000 | -3.6% | 87,400 | 0.0% | 0.39% | -2.0% | |
ATHN | Sell | ATHENAHEALTH INC | $5,770,000 | -72.7% | 51,200 | -74.6% | 0.38% | -72.3% |
SAGE | Sell | SAGE THERAPEUTICS INC | $5,757,000 | -33.7% | 81,000 | -52.4% | 0.38% | -32.6% |
TTPH | TETRAPHASE PHARMACEUTICALS I | $5,514,000 | +128.0% | 600,000 | 0.0% | 0.36% | +132.5% | |
NBIX | NEUROCRINE BIOSCIENCES INC | $5,413,000 | +11.9% | 125,000 | 0.0% | 0.36% | +13.7% | |
INCY | INCYTE CORP | $5,347,000 | +33.3% | 40,000 | 0.0% | 0.35% | +35.6% | |
EPZM | EPIZYME INC | $4,716,000 | +41.7% | 275,000 | 0.0% | 0.31% | +43.8% | |
ALNY | ALNYLAM PHARMACEUTICALS INC | $4,613,000 | +36.9% | 90,000 | 0.0% | 0.30% | +39.3% | |
GLPG | GALAPAGOS NVspon adr | $4,482,000 | +34.3% | 52,000 | 0.0% | 0.30% | +36.9% | |
ACRS | Sell | ACLARIS THERAPEUTICS INC | $4,175,000 | -30.1% | 140,000 | -36.4% | 0.28% | -28.9% |
TSRO | Sell | TESARO INC | $4,001,000 | -54.2% | 26,000 | -60.0% | 0.26% | -53.4% |
VYGR | VOYAGER THERAPEUTICS INC | $3,972,000 | +3.9% | 300,000 | 0.0% | 0.26% | +5.6% | |
RGEN | REPLIGEN CORP | $3,872,000 | +14.2% | 110,000 | 0.0% | 0.26% | +15.8% | |
BOLD | AUDENTES THERAPEUTICS INC | $3,834,000 | -6.7% | 225,000 | 0.0% | 0.25% | -4.9% | |
VRTX | VERTEX PHARMACEUTICALS INC | $3,784,000 | +48.5% | 34,600 | 0.0% | 0.25% | +51.2% | |
MYOV | New | MYOVANT SCIENCES LTD | $3,463,000 | – | 295,000 | +100.0% | 0.23% | – |
ATRC | ATRICURE INC | $3,447,000 | -2.2% | 180,000 | 0.0% | 0.23% | -0.4% | |
TCON | Buy | TRACON PHARMACEUTICALS INC | $3,375,000 | -20.4% | 900,000 | +4.0% | 0.22% | -19.2% |
CHRS | COHERUS BIOSCIENCES INC | $3,067,000 | -24.9% | 145,000 | 0.0% | 0.20% | -23.7% | |
NTUS | NATUS MEDICAL INC DEL | $2,944,000 | +12.8% | 75,000 | 0.0% | 0.20% | +14.7% | |
AQXP | AQUINOX PHARMACEUTICALS INC | $2,921,000 | +1.1% | 175,000 | 0.0% | 0.19% | +2.7% | |
MGNX | Sell | MACROGENICS INC | $2,734,000 | -81.6% | 147,000 | -79.7% | 0.18% | -81.2% |
CTMX | CYTOMX THERAPEUTICS INC | $2,591,000 | +57.1% | 150,000 | 0.0% | 0.17% | +60.7% | |
ACHN | New | ACHILLION PHARMACEUTICALS IN | $2,526,000 | – | 600,000 | +100.0% | 0.17% | – |
SYRS | SYROS PHARMACEUTICALS INC | $2,390,000 | +31.0% | 150,000 | 0.0% | 0.16% | +32.8% | |
CDTX | CIDARA THERAPEUTICS INC | $2,059,000 | -25.0% | 264,000 | 0.0% | 0.14% | -24.0% | |
JUNO | JUNO THERAPEUTICS INC | $1,997,000 | +17.7% | 90,000 | 0.0% | 0.13% | +20.0% | |
SEP | Buy | SPECTRA ENERGY PARTNERS LP | $1,659,000 | +3.4% | 38,000 | +8.6% | 0.11% | +5.8% |
ALDR | Sell | ALDER BIOPHARMACEUTICALS INC | $1,643,000 | -63.3% | 79,000 | -63.3% | 0.11% | -62.5% |
BLCM | Sell | BELLICUM PHARMACEUTICALS INC | $1,604,000 | -52.9% | 130,000 | -48.0% | 0.11% | -52.3% |
TIG | TIGENIXsponsored ads | $1,560,000 | +7.0% | 100,000 | 0.0% | 0.10% | +8.4% | |
HTGC | Sell | HERCULES CAPITAL INC | $1,513,000 | +1.1% | 100,000 | -5.7% | 0.10% | +3.1% |
ARAY | ACCURAY INC | $1,454,000 | +3.2% | 306,200 | 0.0% | 0.10% | +4.3% | |
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $1,412,000 | +27.6% | 43,000 | +11.7% | 0.09% | +29.2% |
BEP | Sell | BROOKFIELD RENEWABLE PARTNERpartnership unit | $1,323,000 | -6.2% | 44,500 | -6.3% | 0.09% | -4.3% |
DRNA | DICERNA PHARMACEUTICALS INC | $1,282,000 | +18.0% | 377,000 | 0.0% | 0.08% | +19.7% | |
AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $1,270,000 | -51.3% | 184,100 | -34.0% | 0.08% | -50.6% |
NYLD | Buy | NRG YIELD INCcl c | $1,239,000 | +20.6% | 70,000 | +7.7% | 0.08% | +22.4% |
JCI | Sell | JOHNSON CTLS INTL PLC | $1,243,000 | +1.3% | 29,500 | -1.0% | 0.08% | +2.5% |
ABB | Buy | ABB LTDsponsored adr | $1,182,000 | +32.1% | 50,500 | +18.8% | 0.08% | +34.5% |
BDN | Sell | BRANDYWINE RLTY TRsh ben int new | $982,000 | -4.1% | 60,500 | -2.4% | 0.06% | -3.0% |
HMC | Sell | HONDA MOTOR LTD | $908,000 | -14.7% | 30,000 | -17.8% | 0.06% | -13.0% |
PTI | Sell | PROTEOSTASIS THERAPEUTICS IN | $845,000 | -68.7% | 108,000 | -50.9% | 0.06% | -68.0% |
KALV | New | KALVISTA PHARMACEUTICALS INC | $766,000 | – | 98,100 | +100.0% | 0.05% | – |
FHB | Buy | FIRST HAWAIIAN INC | $718,000 | +79.5% | 24,000 | +108.7% | 0.05% | +84.6% |
BG | Buy | BUNGE LIMITED | $674,000 | +21.2% | 8,500 | +10.4% | 0.04% | +25.0% |
GLBL | Buy | TERRAFORM GLOBAL INCcl a | $600,000 | +171.5% | 125,000 | +123.2% | 0.04% | +185.7% |
WBK | Buy | WESTPAC BKG CORPsponsored adr | $548,000 | +41.6% | 20,500 | +24.2% | 0.04% | +44.0% |
ETN | EATON CORP PLC | $482,000 | +10.6% | 6,500 | 0.0% | 0.03% | +14.3% | |
LPT | Sell | LIBERTY PPTY TRsh ben int | $463,000 | -9.2% | 12,000 | -7.0% | 0.03% | -6.1% |
VTR | Buy | VENTAS INC | $455,000 | +21.3% | 7,000 | +16.7% | 0.03% | +25.0% |
ERIC | Buy | ERICSSONadr b sek 10 | $392,000 | +40.0% | 59,000 | +22.9% | 0.03% | +44.4% |
WELL | Buy | WELLTOWER INC | $390,000 | +16.4% | 5,500 | +10.0% | 0.03% | +18.2% |
LXP | Sell | LEXINGTON REALTY TRUST | $384,000 | -13.3% | 38,500 | -6.1% | 0.02% | -13.8% |
TERP | New | TERRAFORM PWR INC | $136,000 | – | 11,000 | +100.0% | 0.01% | – |
ZSAN | Exit | ZOSANO PHARMA CORP | $0 | – | -272,000 | -100.0% | -0.01% | – |
NSC | Exit | NORFOLK SOUTHERN CORP | $0 | – | -2,700 | -100.0% | -0.02% | – |
BBN | Exit | BLACKROCK TAX MUNICPAL BD TR | $0 | – | -14,000 | -100.0% | -0.02% | – |
BIP | Exit | BROOKFIELD INFRAST PARTNERSlp int unit | $0 | – | -11,462 | -100.0% | -0.02% | – |
TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -275,000 | -100.0% | -0.04% | – |
APU | Exit | AMERIGAS PARTNERS L Punit l p int | $0 | – | -12,900 | -100.0% | -0.04% | – |
CPPL | Exit | COLUMBIA PIPELINE PARTNERS L | $0 | – | -45,000 | -100.0% | -0.05% | – |
OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -190,000 | -100.0% | -0.10% | – |
NVAX | Exit | NOVAVAX INC | $0 | – | -1,449,700 | -100.0% | -0.12% | – |
TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -537,600 | -100.0% | -0.16% | – |
HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -225,000 | -100.0% | -0.19% | – |
CSLT | Exit | CASTLIGHT HEALTH INCcl b | $0 | – | -1,170,000 | -100.0% | -0.38% | – |
WAB | Exit | WABTEC CORP | $0 | – | -160,000 | -100.0% | -0.86% | – |
BWA | Exit | BORGWARNER INC | $0 | – | -440,000 | -100.0% | -1.13% | – |
MBBYF | Exit | MOBILEYE N V AMSTELVEEN | $0 | – | -873,800 | -100.0% | -2.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 40 | Q3 2023 | 3.2% |
PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
VERACYTE INC | 38 | Q3 2023 | 1.5% |
LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.